Skip Navigation

Defeating Cancer Resistance

MasterKey Therapies: One Solution for Many Mutations

Our Pipeline

Lines shining through keyhole

Our MasterKey therapies are designed to address broad genetically defined patient populations, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat CNS disease. Our efforts are focused on non-small cell lung cancer (NSCLC) and glioblastoma (GBM).

VIEW OUR PIPELINE
Old woman looks up at old man